tiprankstipranks
Trending News
More News >
Max India Ltd (IN:MAXIND)
:MAXIND
India Market
Advertisement

Max India Ltd (MAXIND) AI Stock Analysis

Compare
1 Followers

Top Page

IN:MAXIND

Max India Ltd

(MAXIND)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 4o)
Rating:45Neutral
Price Target:
₹219.00
▲(0.60% Upside)
Max India Ltd's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenue, profitability issues, and liquidity challenges. Technical analysis provides a slightly positive outlook due to recent price trends, but bearish momentum indicators and valuation concerns, including a negative P/E ratio, weigh heavily on the stock's attractiveness.

Max India Ltd (MAXIND) vs. iShares MSCI India ETF (INDA)

Max India Ltd Business Overview & Revenue Model

Company DescriptionMax India Limited provides services related to senior living communities. It owns, develops, constructs, operates, and establishes residential communities for seniors. The company also offers daily living and memory care, home care, management and consultancy, and shared services, as well as medicare products. In addition, it is involved in the learning and development activities; and leasing of real estate properties. The company was formerly known as Advaita Allied Health Services Limited. Max India Limited was incorporated in 2019 and is based in Noida, India.
How the Company Makes MoneyMax India Ltd generates revenue through its various business segments, which include healthcare facilities, senior living communities, and health insurance services. The company's healthcare facilities contribute to its income by offering medical services, hospital management, and patient care. Senior living communities generate revenue through occupancy fees, service charges, and related offerings for the elderly. Additionally, Max India's health insurance segment earns money by providing insurance plans, collecting premiums, and managing risk. The company may also engage in strategic partnerships and collaborations to enhance its service offerings and expand its market presence, further contributing to its revenue streams.

Max India Ltd Financial Statement Overview

Summary
Max India Ltd is experiencing substantial financial challenges across all financial statements. The income statement shows declining revenue and profitability, while the balance sheet reflects increased leverage and reduced equity. Cash flow analysis indicates significant liquidity issues and operational cash generation difficulties. The company is facing a tough financial situation, with the need for strategic realignment and operational improvements to stabilize and improve its financial health.
Income Statement
35
Negative
Max India Ltd's income statement reveals significant challenges. The company has experienced a persistent decline in revenue, with a notable drop in total revenue from 2023 to 2025. Gross profit margins have turned negative, reflecting inefficiencies in cost management. The net profit margin has consistently been negative, highlighting ongoing losses. EBIT and EBITDA margins also show deterioration, indicating operational inefficiencies. Overall, the income statement reflects a struggling business with declining revenue and profitability issues.
Balance Sheet
45
Neutral
The balance sheet of Max India Ltd shows a mixed picture. The debt-to-equity ratio has increased, indicating rising leverage and financial risk. Stockholders' equity has decreased, reducing the equity cushion against liabilities. However, the company maintains a relatively high level of cash and short-term investments, providing some financial flexibility. The equity ratio has declined, suggesting increased reliance on debt financing. Overall, the balance sheet reflects rising leverage and reduced equity, raising concerns about financial stability.
Cash Flow
30
Negative
Cash flow analysis for Max India Ltd indicates significant challenges. The company has experienced negative operating cash flow, reflecting difficulties in generating cash from core operations. Free cash flow has also been negative, exacerbating financial strain. The operating cash flow to net income ratio is unfavorable, highlighting inefficiencies in translating income into cash flow. Overall, the cash flow statement suggests liquidity issues and operational cash generation challenges.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.49B1.45B1.58B2.13B1.69B1.21B
Gross Profit367.70M-26.20M942.71M1.17B1.06B35.37M
EBITDA-947.30M-1.12B-376.40M92.77M823.00K-177.47M
Net Income-1.16B-1.40B-563.76M-104.00M-161.36M-531.16M
Balance Sheet
Total Assets0.006.33B6.84B7.53B8.54B9.98B
Cash, Cash Equivalents and Short-Term Investments2.49B1.43B2.96B3.86B3.99B4.47B
Total Debt0.001.02B435.65M453.00M607.63M1.45B
Total Liabilities-4.45B2.74B1.92B2.11B2.17B3.44B
Stockholders Equity4.45B3.59B4.92B5.42B6.37B6.53B
Cash Flow
Free Cash Flow0.00-1.47B-1.31B657.50M597.96M609.16M
Operating Cash Flow0.00-1.12B-1.02B694.10M664.96M726.67M
Investing Cash Flow0.00306.30M1.59B1.24B322.51M125.23M
Financing Cash Flow0.00-124.13M-289.96M-1.19B-939.41M-733.10M

Max India Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price217.70
Price Trends
50DMA
213.76
Positive
100DMA
201.11
Positive
200DMA
207.88
Positive
Market Momentum
MACD
0.36
Negative
RSI
54.60
Neutral
STOCH
33.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MAXIND, the sentiment is Positive. The current price of 217.7 is above the 20-day moving average (MA) of 214.07, above the 50-day MA of 213.76, and above the 200-day MA of 207.88, indicating a bullish trend. The MACD of 0.36 indicates Negative momentum. The RSI at 54.60 is Neutral, neither overbought nor oversold. The STOCH value of 33.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MAXIND.

Max India Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
₹8.48B24.297.44%1.71%-1.83%-41.16%
64
Neutral
₹8.05B40.736.13%21.65%73.16%
62
Neutral
₹8.22B19.0851.51%12.37%-17.98%
57
Neutral
₹6.04B20.2813.20%37.51%122.52%
45
Neutral
₹11.38B-3.54%-94.33%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:MAXIND
Max India Ltd
217.70
-14.62
-6.29%
IN:KILITCH
Kilitch Drugs (India) Limited
345.65
15.96
4.84%
IN:KOPRAN
Kopran Limited
175.70
-132.81
-43.05%
IN:LINCOLN
Lincoln Pharmaceuticals Ltd
533.35
-129.46
-19.53%
IN:SAKAR
Sakar Healthcare Ltd
366.80
47.65
14.93%
IN:WANBURY
Wanbury Limited
250.05
-2.85
-1.13%

Max India Ltd Corporate Events

Max India Limited Announces Rs. 125 Crore Rights Issue
Apr 17, 2025

Max India Limited has announced a proposed rights issue of fully paid-up equity shares to raise up to Rs. 125 Crores. This initiative is aimed at eligible shareholders and is expected to strengthen the company’s financial position, potentially impacting its market presence positively. The rights issue reflects Max India’s strategic move to enhance shareholder value and support its growth objectives.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 26, 2025